Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis.
Ostberg T, Wähämaa H, Palmblad K, Ito N, Stridh P, Shoshan M, Lotze MT, Harris HE, Andersson U
Arthritis Res Ther 2008, 10:R1
[Full text] [PubMed] [Related articles] [F1000 Medicine] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease
Pisetsky DS, Erlandsson-Harris H, Andersson U
Arthritis Research & Therapy 2008, 10:209 (30 June 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.




Research article    
Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients a prospective clinical study
Sundberg E, Grundtman C, af Klint E, Lindberg J, Ernestam S, Ulfgren AK, Harris HE, Andersson U
Arthritis Research & Therapy 2008, 10:R33 (17 March 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [F1000 Medicine] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.